{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:46:42Z","timestamp":1790628402471,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"PIELenRed consortium for their contribution to this work"},{"name":"Antonio Balas for the advice on the haplotype population"},{"name":"Juliette Siegfried and her team at ServingMed"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.phrs.2016.11.027","type":"journal-article","created":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T20:39:27Z","timestamp":1479847167000},"page":"168-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"special_numbering":"C","title":["Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS\/TEN are different from those found for the same AED-induced DRESS in the Spanish population"],"prefix":"10.1016","volume":"115","author":[{"given":"Elena","family":"Ram\u00edrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Bell\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi Y.","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto M.","family":"Borobia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"de Abajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Lerma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Moreno Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Casta\u00f1er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Caba\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Fiandor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Gonz\u00e1lez-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Herranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Cachafeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Gonz\u00e1lez-Herrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Aramburu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Laosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio J.","family":"Carcas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Fr\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.11.027_bib0005","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.phrs.2016.11.027_bib0010","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.11.027_bib0015","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1590\/S0365-05962012000300013","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS)\/drug-induced hypersensitivity syndrome (DIHS): a review of current concepts","volume":"87","author":"Criado","year":"2012","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.phrs.2016.11.027_bib0020","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7326\/0003-4819-139-8-200310210-00012","article-title":"Delayed drug hypersensitivity reactions","volume":"139","author":"Pichler","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.phrs.2016.11.027_bib0025","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.jaci.2010.11.048","article-title":"Immune pathomechanism of drug hypersensitivity reactions","volume":"127","author":"Pichler","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.phrs.2016.11.027_bib0030","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells","volume":"114","author":"Nassif","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.phrs.2016.11.027_bib0035","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2016.11.027_bib0040","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.4049\/jimmunol.0804002","article-title":"Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome","volume":"182","author":"Takahashi","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2016.11.027_bib0045","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000335624","article-title":"Drug-induced hypersensitivity syndrome: recent advances in the diagnosis, pathogenesis and management","volume":"97","author":"Shiohara","year":"2012","journal-title":"Chem. Immunol. Allergy"},{"key":"10.1016\/j.phrs.2016.11.027_bib0050","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/ACI.0b013e3282370c5f","article-title":"Human leukocyte antigens and drug hypersensitivity","volume":"7","author":"Chung","year":"2007","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.phrs.2016.11.027_bib0055","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2217\/pgs.14.65","article-title":"Pharmacogenetics of antiepileptic drug-induced hypersensitivity","volume":"15","author":"Bloch","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.phrs.2016.11.027_bib0060","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1212\/WNL.49.2.542","article-title":"Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study","volume":"49","author":"Tennis","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2016.11.027_bib0065","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1528-1157.1999.tb00807.x","article-title":"Lamotrigine-associated rash: risk\/benefit considerations in adults and children","volume":"40","author":"Guberman","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2016.11.027_bib0070","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1528-1167.2006.00423.x","article-title":"Predictors of lamotrigine-associated rash","volume":"47","author":"Hirsch","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2016.11.027_bib0075","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000335613","article-title":"Genetics and the potential for predictive tests in adverse drug reactions","volume":"97","author":"Pirmohamed","year":"2012","journal-title":"Chem. Immunol. Allergy"},{"key":"10.1016\/j.phrs.2016.11.027_bib0080","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.eplepsyres.2013.05.004","article-title":"Predictive markers for carbamazepine and lamotrigine-induced maculopapular exanthema in Han Chinese","volume":"106","author":"Li","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.phrs.2016.11.027_bib0085","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/FPC.0000000000000021","article-title":"HLA alleles and hypersensitivity to carbamazepine: anupdated systematic review with meta-analysis","volume":"4","author":"Grover","year":"2014","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.phrs.2016.11.027_bib0090","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2217\/pgs.14.65","article-title":"Pharmacogenetics of antiepileptic drug-induced hypersensitivity","volume":"15","author":"Bloch","year":"2014","journal-title":"Pharmacogenomics"},{"issue":"January (1)","key":"10.1016\/j.phrs.2016.11.027_bib0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1399-0039.2010.01578.x","article-title":"Allelic and haplotypic HLA frequency distribution in Spanish hematopoietic patients: implications for unrelated donor searching","volume":"77","author":"Balas","year":"2011","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.phrs.2016.11.027_bib0100","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.phrs.2016.11.027_bib0105","series-title":"Principios de Epidemiolog\u00eda del Medicamento","first-page":"147","article-title":"La notificaci\u00f3n espont\u00e1nea de reacciones adversas a medicamentos","author":"Capell\u00e1","year":"1993"},{"issue":"1","key":"10.1016\/j.phrs.2016.11.027_bib0110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2016.11.027_bib0115","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1398-9995.2004.00547.x","article-title":"The lymphocyte transformation test in the diagnosis of drug hypersensitivity","volume":"59","author":"Pichler","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.phrs.2016.11.027_bib0120","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1399-0039.2008.01111.x","article-title":"Re-evaluation of heterogeneity in HLA-B*510101 associated with Behcet\u2019s disease","volume":"72","author":"Takemoto","year":"2008","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.phrs.2016.11.027_bib0125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-med-050913-022745","article-title":"T cell-mediated hypersensitivity reactions to drugs","volume":"66","author":"Pavlos","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.phrs.2016.11.027_bib0130","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0014-5793(90)81382-X","article-title":"Identification of the binding sites of benzyl penicilloyl, the allergenic metabolite of penicillin, on the serum albumin molecule","volume":"263","author":"Yvon","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/j.phrs.2016.11.027_bib0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2332\/allergolint.55.17","article-title":"Pharmacological interaction of drugs with immune receptors: the p-i concept","volume":"55","author":"Pichler","year":"2006","journal-title":"Allergol. Int."},{"key":"10.1016\/j.phrs.2016.11.027_bib0140","doi-asserted-by":"crossref","first-page":"F21","DOI":"10.1097\/QAD.0b013e328355fe8f","article-title":"Abacavir induces loading of novel self-peptides into HLA-B*57:01: an autoimmune model for HLA-associated drug hypersensitivity","volume":"26","author":"Norcross","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.phrs.2016.11.027_bib0145","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jama.2014.7859","article-title":"Taiwan severe cutaneous adverse reaction consortium; Japan pharmacogenomics data science consortium genetic variants associated with phenytoin-related severe cutaneous adverse reactions","volume":"312","author":"Chung","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2016.11.027_bib0150","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/FPC.0000000000000211","article-title":"Associations between HLA class I and cytochrome P450 2 C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population","volume":"26","author":"Tassaneeyakul","year":"2016","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.phrs.2016.11.027_bib0155","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1111\/epi.13087","article-title":"The HLA-A*2402\/Cw*0102 haplotype is associated with lamotrigine-induced maculopapular eruption in the Korean population","volume":"56","author":"Moon","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2016.11.027_bib0160","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.eplepsyres.2015.09.011","article-title":"Do HLA-A markers predict skin-reactions from aromatic antiepileptic drugs in a Norwegian population? A case control study","volume":"118","author":"Shirzadi","year":"2015","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.phrs.2016.11.027_bib0165","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1001\/jama.1986.03380240052027","article-title":"Drug-induced cutaneous reactions a report from the Boston collaborative drug surveillance program on 15,438 consecutive inpatients, 1975 to 1982","volume":"256","author":"Bigby","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2016.11.027_bib0170","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1398-9995.1997.tb01017.x","article-title":"Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey","volume":"52","author":"Hunziker","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.phrs.2016.11.027_bib0175","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.mcna.2010.04.001","article-title":"Delayed cutaneous manifestations of drug hypersensitivity","volume":"94","author":"Bircher","year":"2010","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.phrs.2016.11.027_bib0180","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/FPC.0b013e32832c347d","article-title":"High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients","volume":"19","author":"Kazeem","year":"2009","journal-title":"Pharmacogenet. Genomics"},{"issue":"15","key":"10.1016\/j.phrs.2016.11.027_bib0185","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.2217\/pgs.14.135","article-title":"HLA-A*02:01:01\/-B*35:01:01\/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients","volume":"15","author":"Fricke-Galindo","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.phrs.2016.11.027_bib0190","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","article-title":"RegiSCAR study group: a European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs","volume":"18","author":"Lonjou","year":"2008","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.phrs.2016.11.027_bib0195","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.eplepsyres.2008.04.003","article-title":"Cross-reactivity pattern of rash from current aromatic antiepileptic drugs","volume":"80","author":"Alvestad","year":"2008","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.phrs.2016.11.027_bib0200","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"A marker for Stevens\u2013Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.11.027_bib0205","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/clpt.2012.189","article-title":"Pirmohamed M, Alfirevic A. HLA genotype and carbamazepine-induced cutaneous adverse reactions: a systematic review","volume":"92","author":"Yip","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2016.11.027_bib0210","unstructured":"The Allele Frequency Net Database. Available from: http:\/\/www.allelefrequencies.net."},{"issue":"April (6)","key":"10.1016\/j.phrs.2016.11.027_bib0215","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2217\/pgs.16.10","article-title":"The HLA-B*15:02 allele in a Spanish Romani patient with carbamazepine-induced Stevens-Johnson syndrome","volume":"17","author":"Bell\u00f3n","year":"2016","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.phrs.2016.11.027_bib0220","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.phrs.2016.11.027_bib0225","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans","volume":"364","author":"McCormak","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.11.027_bib0230","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/tpj.2013.40","article-title":"HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis","volume":"14","author":"Genin","year":"2014","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.phrs.2016.11.027_bib0235","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sj.bmt.1703876","article-title":"Common genomic HLA haplotypes contributing to successful donor search in unrelated hematopoietic transplantation","volume":"31","author":"Pedron","year":"2003","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.phrs.2016.11.027_bib0240","unstructured":"T. Imanishi, T. Akaza, A. Kimura, K. Tokunaga, T. Gojorobi Estimation of allele and haplotype frequencies for HLA and complement loci. In: Tsuji K, Aizawa M, Sasazuki T (eds). HLA 1991. Proceedings of the 11th International Histocompatibility Workshop and Conference, Oxford University Press : Oxford, 1992, pp. 76\u201379."},{"issue":"June (14)","key":"10.1016\/j.phrs.2016.11.027_bib0245","article-title":"Somatic mutation in the HLA-B gene of a patient with acute myelogenous leukaemia","author":"Planelles","year":"2016","journal-title":"HLA"},{"key":"10.1016\/j.phrs.2016.11.027_bib0250","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/tan.12362","article-title":"Somatic mutation in acute myelogenous leukemia cells imitate novel germline HLA-A allele: a case report","volume":"83","author":"Mrazek","year":"2014","journal-title":"Tissue Antigens"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816305904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816305904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T17:43:30Z","timestamp":1568569410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816305904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":50,"alternative-id":["S1043661816305904"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.11.027","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS\/TEN are different from those found for the same AED-induced DRESS in the Spanish population","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}